NeuroOne Medical Technologies Corp (NASDAQ: NMTC) kicked off on Friday, up 3.42% from the previous trading day, before settling in for the closing price of $0.74. Over the past 52 weeks, NMTC has traded in a range of $0.40-$1.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 23.14%. While this was happening, its average annual earnings per share was recorded 71.74%. With a float of $44.01 million, this company’s outstanding shares have now reached $49.82 million.
NeuroOne Medical Technologies Corp (NMTC) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of NeuroOne Medical Technologies Corp is 11.98%, while institutional ownership is 42.03%. The most recent insider transaction that took place on Aug 20 ’25, was worth 24,210. Before that another transaction happened on Jun 04 ’25, when Company’s Business Development Director sold 10,000 for $0.58, making the entire transaction worth $5,804. This insider now owns 261,491 shares in total.
NeuroOne Medical Technologies Corp (NMTC) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 71.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.93% during the next five years compared to 23.14% growth over the previous five years of trading.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Trading Performance Indicators
Take a look at NeuroOne Medical Technologies Corp’s (NMTC) current performance indicators. Last quarter, stock had a quick ratio of 5.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.16, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of NeuroOne Medical Technologies Corp (NMTC)
Compared to the last year’s volume of 0.27 million, its volume of 0.12 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 10.15%.
During the past 100 days, NeuroOne Medical Technologies Corp’s (NMTC) raw stochastic average was set at 56.34%, which indicates a significant increase from 12.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0740 in the past 14 days, which was higher than the 0.0601 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7751, while its 200-day Moving Average is $0.8064. Nevertheless, the first resistance level for the watch stands at $0.7745 in the near term. At $0.7847, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7995. If the price goes on to break the first support level at $0.7495, it is likely to go to the next support level at $0.7347. Should the price break the second support level, the third support level stands at $0.7245.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Key Stats
The company with the Market Capitalisation of 38.21 million has total of 50,000K Shares Outstanding. Its annual sales at the moment are 3,450 K in contrast with the sum of -12,320 K annual income. Company’s last quarter sales were recorded 1,700 K and last quarter income was -1,500 K.
